BIOLASE, Inc. to Report Second Quarter 2020 Results on August 13, 2020
BIOLASE, Inc. (NASDAQ: BIOL) will release its Q2 2020 financial results on August 13, 2020, after market close. The company will also host a conference call at 4:30 p.m. ET to discuss these results. For U.S./Canada participants, the dial-in number is 800-367-2403, while international participants can call 334-777-6978, using Conference ID 9516164. An audio archive of the call will be available for 30 days on the BIOLASE website.
BIOLASE is a leader in dental laser systems, developing innovative solutions with over 41,200 systems sold in 80+ countries.
- None.
- None.
FOOTHILL RANCH, Calif., Aug. 6, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2020 financial and operating results on Thursday, August 13, 2020 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is 800-367-2403. For international participants outside the U.S./Canada, the dial-in number is 334-777-6978. For all callers, refer to the Conference ID 9516164. To access the live webcast, go to BIOLASE Investor Events Page.
An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-inc-to-report-second-quarter-2020-results-on-august-13-2020-301107355.html
SOURCE BIOLASE, Inc.
FAQ
When will BIOLASE report its Q2 2020 financial results?
What time is the BIOLASE conference call on August 13, 2020?
What are the dial-in numbers for the BIOLASE conference call?
How can I access the BIOLASE conference call?
Where can I find the audio archive of the BIOLASE conference call?
